PMDA — authorised 19 December 2016
- Marketing authorisation holder: Gilead Sciences
- Status: approved
PMDA authorised Vemlidy on 19 December 2016
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 19 December 2016.
Gilead Sciences holds the Japanese marketing authorisation.